Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Statistics

Total Valuation

AKRO has a market cap or net worth of $3.37 billion. The enterprise value is $2.32 billion.

Market Cap	3.37B
Enterprise Value	2.32B

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

AKRO has 79.99 million shares outstanding. The number of shares has increased by 25.25% in one year.

Current Share Class	79.99M
Shares Outstanding	79.99M
Shares Change (YoY)	+25.25%
Shares Change (QoQ)	+3.90%
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	102.40%
Float	67.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.29
P/TBV Ratio	3.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.66, with a Debt / Equity ratio of 0.04.

Current Ratio	12.66
Quick Ratio	12.29
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-67.37

Financial Efficiency

Return on equity (ROE) is -31.14% and return on invested capital (ROIC) is -21.19%.

Return on Equity (ROE)	-31.14%
Return on Assets (ROA)	-20.36%
Return on Invested Capital (ROIC)	-21.19%
Return on Capital Employed (ROCE)	-30.65%
Revenue Per Employee	n/a
Profits Per Employee	-$4.51M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.56% in the last 52 weeks. The beta is -0.24, so AKRO's price volatility has been lower than the market average.

Beta (5Y)	-0.24
52-Week Price Change	+57.56%
50-Day Moving Average	48.40
200-Day Moving Average	43.61
Relative Strength Index (RSI)	33.17
Average Volume (20 Days)	948,082

Short Selling Information

The latest short interest is 8.89 million, so 11.11% of the outstanding shares have been sold short.

Short Interest	8.89M
Short Previous Month	9.22M
Short % of Shares Out	11.11%
Short % of Float	13.12%
Short Ratio (days to cover)	9.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-321.48M
Pretax Income	-204.18M
Net Income	-283.96M
EBITDA	-321.46M
EBIT	-321.48M
Earnings Per Share (EPS)	-$3.78

Balance Sheet

The company has $742.32 million in cash and $36.34 million in debt, giving a net cash position of $1.05 billion or $13.13 per share.

Cash & Cash Equivalents	742.32M
Total Debt	36.34M
Net Cash	1.05B
Net Cash Per Share	$13.13
Equity (Book Value)	1.03B
Book Value Per Share	12.84
Working Capital	704.20M

Cash Flow

Operating Cash Flow	-253.42M
Capital Expenditures	n/a
Free Cash Flow	-253.42M
FCF Per Share	-$3.17

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.25%
Shareholder Yield	-25.25%
Earnings Yield	-8.42%
FCF Yield	-7.51%

Analyst Forecast

The average price target for AKRO is $80.38, which is 90.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$80.38
Price Target Difference	90.56%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2